Showing 19,501 - 19,520 results of 38,854 for search '(( significantly ((high decrease) OR (high disease)) ) OR ( significant decrease decrease ))', query time: 0.71s Refine Results
  1. 19501

    Image 2_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.jpeg by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  2. 19502

    Image 4_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.jpeg by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  3. 19503

    Data Sheet 1_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.pdf by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  4. 19504

    Image 3_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.jpeg by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  5. 19505

    Image 1_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.jpeg by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  6. 19506

    Video 1_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.mp4 by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  7. 19507

    Data Sheet 2_Low intensity gamma-frequency TMS safely modulates gamma oscillations in probable mild Alzheimer’s dementia: a randomized 2 × 2 crossover pilot study.pdf by A. J. Mimenza-Alvarado (21367160)

    Published 2025
    “…Importantly, the intervention was well-tolerated, with no significant adverse effects reported.</p>Discussion<p>Low intensity gTMS has shown the capability to induce significant changes in brain activity, particularly in gamma oscillations. …”
  8. 19508
  9. 19509

    Data Sheet 1_Energy landscape analysis of health checkup data clarified multiple pathways to diabetes development in obese and non-obese subjects.pdf by Ryo Ito (469154)

    Published 2025
    “…Aims<p>To clarify the pathways from a healthy state to the diabetes onset via pre-disease states, we applied energy landscape analysis (ELA) to Specific Health Checkup data in Japan.…”
  10. 19510

    Data Sheet 1_Dietary and circulating butyrate are independently associated with kidney function in diabetes: a dual-cohort analysis.pdf by Leying Zhao (14591108)

    Published 2025
    “…However, evidence from large-scale human studies, especially in high-risk diabetic populations, remains limited. …”
  11. 19511
  12. 19512

    Table 1_Nudge theories and strategies influencing adult health behaviors and outcomes in COPD management: a systematic review.docx by Qiuhui Wu (14632760)

    Published 2024
    “…Objective<p>Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with high prevalence and mortality, and self-management is a key component for better outcomes of COPD. …”
  13. 19513

    Table 2_An integrative pharmacology-based study on the pharmacological activity and mechanism of xiaoji-chenpi formula (XCF) against MAFLD.xlsx by Shufei Liang (11074746)

    Published 2025
    “…<p>Metabolic-associated fatty liver disease (MAFLD) is a common chronic metabolic disease worldwide that seriously threatens human health. …”
  14. 19514

    Table 1_Livestock ownership among smallholder farming households in Eastern Zambia: a gendered pathway for enhancing climate resilience?.docx by Bridget Bwalya (20457650)

    Published 2024
    “…Joint livestock ownership significantly increases the total livestock units a household owns. …”
  15. 19515

    Table 1_An integrative pharmacology-based study on the pharmacological activity and mechanism of xiaoji-chenpi formula (XCF) against MAFLD.xlsx by Shufei Liang (11074746)

    Published 2025
    “…<p>Metabolic-associated fatty liver disease (MAFLD) is a common chronic metabolic disease worldwide that seriously threatens human health. …”
  16. 19516

    Data Sheet 1_An integrative pharmacology-based study on the pharmacological activity and mechanism of xiaoji-chenpi formula (XCF) against MAFLD.docx by Shufei Liang (11074746)

    Published 2025
    “…<p>Metabolic-associated fatty liver disease (MAFLD) is a common chronic metabolic disease worldwide that seriously threatens human health. …”
  17. 19517

    Data Sheet 1_Trends and future predictions of chronic kidney disease due to diabetes mellitus type 2 attributable to dietary risks: insights based on GBD 2021 data.csv by Ming Xu (151206)

    Published 2025
    “…Geographic disparities in T2DM trends are evident, with the most significant increases in age-standardized mortality rates (ASMR) and age-standardized DALY rates (ASDR) observed in regions such as high-income North America and Central Latin America. …”
  18. 19518
  19. 19519

    Supplementary file 1_Bioinformatics analysis combined with experimental validation reveals the novel mechanisms of multi-targets of dapagliflozin attenuating diabetic liver injury.... by Pengyu Wang (6680312)

    Published 2025
    “…Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, has shown significant therapeutic benefits in clinical trials for the management of diabetes However, the specific mechanism on the treatment of diabetic liver injury with dapagliflozin is not fully understood. …”
  20. 19520

    Data Sheet 1_Neuraminidase as a novel therapeutic management strategy for Alzheimer’s disease: evidenced through molecular docking, molecular dynamic simulation and gene expression... by Sami I. Alzarea (14055507)

    Published 2025
    “…Introduction<p>Neuraminidase in humans is studied to see how well repurposed oseltamivir works for treating Alzheimer’s disease (AD) using methods like molecular docking, molecular dynamic (MD) simulation, and gene expression analysis. …”